1. Home
  2. SCPH vs DSX Comparison

SCPH vs DSX Comparison

Compare SCPH & DSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • DSX
  • Stock Information
  • Founded
  • SCPH 2013
  • DSX 1999
  • Country
  • SCPH United States
  • DSX Greece
  • Employees
  • SCPH N/A
  • DSX N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • DSX Marine Transportation
  • Sector
  • SCPH Health Care
  • DSX Consumer Discretionary
  • Exchange
  • SCPH Nasdaq
  • DSX Nasdaq
  • Market Cap
  • SCPH 173.6M
  • DSX 172.5M
  • IPO Year
  • SCPH 2017
  • DSX 2005
  • Fundamental
  • Price
  • SCPH $3.64
  • DSX $1.52
  • Analyst Decision
  • SCPH Strong Buy
  • DSX
  • Analyst Count
  • SCPH 3
  • DSX 0
  • Target Price
  • SCPH $14.00
  • DSX N/A
  • AVG Volume (30 Days)
  • SCPH 423.8K
  • DSX 257.9K
  • Earning Date
  • SCPH 05-14-2025
  • DSX 05-29-2025
  • Dividend Yield
  • SCPH N/A
  • DSX 2.63%
  • EPS Growth
  • SCPH N/A
  • DSX N/A
  • EPS
  • SCPH N/A
  • DSX 0.05
  • Revenue
  • SCPH $41,982,000.00
  • DSX $225,498,000.00
  • Revenue This Year
  • SCPH $109.32
  • DSX N/A
  • Revenue Next Year
  • SCPH $76.95
  • DSX $12.03
  • P/E Ratio
  • SCPH N/A
  • DSX $28.79
  • Revenue Growth
  • SCPH 138.10
  • DSX N/A
  • 52 Week Low
  • SCPH $1.94
  • DSX $1.27
  • 52 Week High
  • SCPH $5.65
  • DSX $3.07
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 66.63
  • DSX 53.14
  • Support Level
  • SCPH $3.23
  • DSX $1.38
  • Resistance Level
  • SCPH $3.74
  • DSX $1.59
  • Average True Range (ATR)
  • SCPH 0.31
  • DSX 0.07
  • MACD
  • SCPH 0.08
  • DSX 0.00
  • Stochastic Oscillator
  • SCPH 93.81
  • DSX 66.67

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.

Share on Social Networks: